Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Japan's Takeda plans to sell consumer health unit for around $3.7 bln - Nikkei

TOKYO, April 24 (Reuters) - Japan's Takeda Pharmaceutical Co
Ltd  4502.T  plans to sell its consumer health unit for around
400 billion yen ($3.72 billion), Nikkei Business reported.
    Possible buyers of the unit include Taisho Pharmaceutical
Co.  4581.T  and large investment funds, Nikkei reported. A
Takeda spokeswoman said the company does not comment on rumours.
    Following its acquisition of Shire Plc in 2019 for $59
billion, Takeda has pledged to dispose of $10 billion worth of
non-core assets to pare down debt.
($1 = 107.6500 yen)

 (Reporting by Rocky Swift; Editing by Muralikumar Anantharaman)
 ((rocky.swift@thomsonreuters.com;))

Recent news on Taisho Pharmaceutical Holdings Co

See all news